References
Ando K, Fujita T, Ito Y, Noda H, Yamashita K. The role of renal haemodynamics in the antihypertensive effect of Captopril. American Heart Journal 111: 347–352, 1986
Fagard R, Fiocchi R, Lijnen P, Staessen J, Moerman E, et al. Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension. British Heart Journal 51: 149–156, 1984
Fujita T, Ando K, Noda H, Sato Y, Yamashita N, et al. Hemodynamic and endocrine changes associated with Captopril in diuretic-resistant hypertensive patients. American Journal of Medicine 73: 341–347, 1982
Fujita T, Ito Y, Noda H, Sato Y, Ando K, et al. Vasodilatory actions of α-human atrial natriuretic peptide and high Ca2+ effects in normal man. Journal of Clinical Investigation 80: 832–840, 1987
Kobrin I, Amodeo C, Ventura HO, Messerli FH, Frohlich ED. Immediate hemodynamic effects of Urapidil in patients with essential hypertension. American Journal of Cardiology 55: 722–725, 1985
Robertson JIS, Stott DJ, Ball SG. Antihypertensive mode of action of ketanserin. Journal of Cardiovascular Pharmacology 10(Suppl. 3): S45–S47, 1987
Vanhoutte PM. 5-hydroxytryptamine and vascular disease. Federation Proceedings 42: 233–237, 1983
Vanhoutte PM, Van Nueten JM, Symoens J, Janssen PAJ. Antihypertensive properties of ketanserin (R 41 468). Federation Proceedings 42: 182–185, 1983
Van Nueten JM, Janssen PAJ, Symoens J, Janssen WJ, Heykants J, et al. Ketanserin. In Scriabine A (Ed.) New cardiovascular drugs, pp. 1–56, Raven Press, New York, 1987
Wenting GJ, Man in’t Veld AJ, Woittiez AJ, Boomsma F, Schalekamp MADH. Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist. British Medical Journal 284: 537–539, 1982
Wenting GJ, Woittiez AJJ, Man in’t Veld AJ, Schalekamp MADH. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension 6: 100–109, 1984
Woittiez AJJ, Wenting GJ, Van den Meiracker AH, Ritsema van Eck HJ, Man in’t Veld AJ, et al. Chronic effect of ketanserin in mild to moderate essential hypertension. Hypertension 8: 167–173, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ito, Y., Isaka, M., Noda, H. et al. Effects of Ketanserin on Systemic and Regional Haemodynamics in Patients with Essential Hypertension. Drugs 36 (Suppl 1), 120–122 (1988). https://doi.org/10.2165/00003495-198800361-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800361-00023